Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIGA: FOLFOX6 vs mFOLFIRINOX in Metastatic Gastric/EGJ Cancer
NCT04442984Phase 2Unknown
- Sponsor
- N.N. Blokhin Russian Cancer Research Center
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in gastric adenocarcinoma, esophagogastric junction adenocarcinoma (GEJA), sponsored by N.N. Blokhin Russian Cancer Research Center. Status: unknown.
02
Drugs
irinotecan
03
Conditions
gastric adenocarcinomaesophagogastric junction adenocarcinoma (GEJA)
Beyond the preview
Go deeper on NCT04442984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04442984.